167 related articles for article (PubMed ID: 35326640)
41. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells.
Romano MF; Lamberti A; Tassone P; Alfinito F; Costantini S; Chiurazzi F; Defrance T; Bonelli P; Tuccillo F; Turco MC; Venuta S
Blood; 1998 Aug; 92(3):990-5. PubMed ID: 9680368
[TBL] [Abstract][Full Text] [Related]
42. NIK inhibitor impairs chronic periodontitis via suppressing non-canonical NF-κB and osteoclastogenesis.
Wang J; Wang B; Lv X; Wang L
Pathog Dis; 2020 Oct; 78(7):. PubMed ID: 32860691
[TBL] [Abstract][Full Text] [Related]
43. Stabilization of NF-κB-Inducing Kinase Suppresses MLL-AF9-Induced Acute Myeloid Leukemia.
Xiu Y; Dong Q; Li Q; Li F; Borcherding N; Zhang W; Boyce B; Xue HH; Zhao C
Cell Rep; 2018 Jan; 22(2):350-358. PubMed ID: 29320732
[TBL] [Abstract][Full Text] [Related]
44. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
[TBL] [Abstract][Full Text] [Related]
45. NF-kB and the CLL microenvironment.
O'Donnell A; Pepper C; Mitchell S; Pepper A
Front Oncol; 2023; 13():1169397. PubMed ID: 37064123
[TBL] [Abstract][Full Text] [Related]
46. DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells.
Horie R; Watanabe M; Okamura T; Taira M; Shoda M; Motoji T; Utsunomiya A; Watanabe T; Higashihara M; Umezawa K
Leukemia; 2006 May; 20(5):800-6. PubMed ID: 16525497
[TBL] [Abstract][Full Text] [Related]
47. The NF-kappaB inhibitor LC-1 has single agent activity in multiple myeloma cells and synergizes with bortezomib.
Walsby EJ; Pratt G; Hewamana S; Crooks PA; Burnett AK; Fegan C; Pepper C
Mol Cancer Ther; 2010 Jun; 9(6):1574-82. PubMed ID: 20515939
[TBL] [Abstract][Full Text] [Related]
48. Negative feedback regulation of NF-κB-inducing kinase is proteasome-dependent but does not require cellular inhibitors of apoptosis.
Gray CM; McCorkell KA; Chunduru SK; McKinlay MA; May MJ
Biochem Biophys Res Commun; 2014 Jul; 450(1):341-6. PubMed ID: 24942881
[TBL] [Abstract][Full Text] [Related]
49. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
[TBL] [Abstract][Full Text] [Related]
50. Role for protein kinase Ctheta (PKCtheta) in TCR/CD28-mediated signaling through the canonical but not the non-canonical pathway for NF-kappaB activation.
Li Y; Sedwick CE; Hu J; Altman A
J Biol Chem; 2005 Jan; 280(2):1217-23. PubMed ID: 15536066
[TBL] [Abstract][Full Text] [Related]
51. NF-κB inducing kinase, a central signaling component of the non-canonical pathway of NF-κB, contributes to ovarian cancer progression.
Uno M; Saitoh Y; Mochida K; Tsuruyama E; Kiyono T; Imoto I; Inazawa J; Yuasa Y; Kubota T; Yamaoka S
PLoS One; 2014; 9(2):e88347. PubMed ID: 24533079
[TBL] [Abstract][Full Text] [Related]
52. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Xu J; Zhou P; Wang W; Sun A; Guo F
J Mol Med (Berl); 2014 Jan; 92(1):77-92. PubMed ID: 24042463
[TBL] [Abstract][Full Text] [Related]
53. Estrogen-dependent activation of NCOA3 couples with p300 and NF-κB to mediate antiapoptotic genes in ER-positive breast cancer cells.
Wang J; Zhou Z
Discov Oncol; 2023 Feb; 14(1):28. PubMed ID: 36853387
[TBL] [Abstract][Full Text] [Related]
54. Specific effects of BCL10 Serine mutations on phosphorylations in canonical and noncanonical pathways of NF-κB activation following carrageenan.
Bhattacharyya S; Borthakur A; Anbazhagan AN; Katyal S; Dudeja PK; Tobacman JK
Am J Physiol Gastrointest Liver Physiol; 2011 Sep; 301(3):G475-86. PubMed ID: 21700900
[TBL] [Abstract][Full Text] [Related]
55. p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.
López-Guerra M; Roué G; Pérez-Galán P; Alonso R; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2009 Apr; 15(8):2767-76. PubMed ID: 19351760
[TBL] [Abstract][Full Text] [Related]
56. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.
Mineva ND; Rothstein TL; Meyers JA; Lerner A; Sonenshein GE
J Biol Chem; 2007 Jun; 282(24):17475-85. PubMed ID: 17446175
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor alpha-induced inflammation is increased but apoptosis is inhibited by common food additive carrageenan.
Bhattacharyya S; Dudeja PK; Tobacman JK
J Biol Chem; 2010 Dec; 285(50):39511-22. PubMed ID: 20937806
[TBL] [Abstract][Full Text] [Related]
58. A NIK-SIX signalling axis controls inflammation by targeted silencing of non-canonical NF-κB.
Liu Z; Mar KB; Hanners NW; Perelman SS; Kanchwala M; Xing C; Schoggins JW; Alto NM
Nature; 2019 Apr; 568(7751):249-253. PubMed ID: 30894749
[TBL] [Abstract][Full Text] [Related]
59. Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-kappaB signal pathway.
Nishioka C; Ikezoe T; Yang J; Koeffler HP; Taguchi H
Leukemia; 2007 May; 21(5):1044-9. PubMed ID: 17344917
[TBL] [Abstract][Full Text] [Related]
60. Cap-translation inhibitor, 4EGI-1, restores sensitivity to ABT-737 apoptosis through cap-dependent and -independent mechanisms in chronic lymphocytic leukemia.
Willimott S; Beck D; Ahearne MJ; Adams VC; Wagner SD
Clin Cancer Res; 2013 Jun; 19(12):3212-23. PubMed ID: 23633452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
